KMID : 1134120160190020112
|
|
Journal of Breast Cancer 2016 Volume.19 No. 2 p.112 ~ p.121
|
|
Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype
|
|
Carol Parise
Vincent Caggiano
|
|
Abstract
|
|
|
Purpose: Asian-American women have equal or better breast cancer survival rates than non-Hispanic white women, but many studies use the aggregate term "Asian/Pacific Islander" (API) or consider breast cancer as a single disease. The purpose of this study was to assess the risk of mortality in seven subgroups of Asian-Americans expressing the estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2) tumor marker subtypes and determine whether the risk of mortality for the aggregate API category is reflective of the risk in all Asian ethnicities.
Methods: The study included data for 110,120 Asian and white women with stage 1 to 4 first primary invasive breast cancer from the California Cancer Registry. The Asian ethnicities identified were Pacific Islander, Southeast Asian (SEA), Indian Subcontinent, Chinese, Japanese, Filipino, and Korean. A Cox regression analysis was used to compute the risk of breast cancer-specific mortality in seven Asian ethnicities and the combined API category versus white women within each of the ER/PR/HER2 subtypes. Hazard ratios (HRs) and 95% confidence intervals (CIs) were computed.
Results: For the ER+/PR+/HER2- subtype, the combined API category showed a 17% (HR, 0.83; 95% CI, 0.76?0.91) lower mortality risk. This was true only for SEA (HR, 0.75; 95% CI, 0.61?0.91) and Japanese women (HR, 0.60; 95% CI, 0.45?0.81). In the ER+/PR-/HER2- subtype, SEA (HR, 0.57; 95% CI, 0.38?0.84) and Filipino women (HR, 0.71; 95% CI, 0.51?0.97) had a lower risk of mortality. Japanese (HR, 0.49; 95% CI, 0.25?0.99) and Filipino women (HR, 0.74; 95% CI, 0.58?0.94) had a lower HR for the ER-/PR-/HER2+ subtype. For triple-positive, ER+/PR+/HER2+ (HR, 0.84; 95% CI, 0.71?0.98) and triple-negative, ER-/PR-/HER2- (HR, 0.84; 95% CI, 0.74?0.94) subtypes, only the API category showed a lower risk of mortality.
Conclusion: Breast cancer-specific mortality among Asian-American women varies according to their specific Asian ethnicity and breast cancer subtype.
|
|
KEYWORD
|
|
Asian Americans, Breast neoplasms, Healthcare disparities, Mortality
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|